Peroxisome proliferator ‐activated receptor activity correlates with poor survival in patients resected for hepatocellular carcinoma

ConclusionPPAR activity in a subset of tumor samples was associated with reduced overall survival indicating that PPAR may be a valuable prognostic biomarker.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - May 1, 2020 Category: Gastroenterology Authors: Hans ‐Christian Pommergaard, Jane Preuss Hasselby, Gro Linno Willemoe, Adela Ralbovska, Andreas Arendtsen Rostved, Allan Rasmussen, Nicolai Aagaard Schultz, Jens Hillingsø, Peter Nørgaard Larsen, Jan‐Michael Kugler Tags: ORIGINAL ARTICLE Source Type: research